Skip to main content
SpringerLink
Log in
Birkhäuser
Book cover

Calcium Channel Blockers

  • Book
  • © 2004

Overview

Authors:
  1. Théophile Godfraind

    1. Université Catholique de Louvain, Bruxelles, Belgium

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Comprehensive overview of the different classes of calcium channel blockers and their mode of action
  • All chapters written by Prof. T. Godfraind, a leading expert in the field

Part of the book series: Milestones in Drug Therapy (MDT)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (10 chapters)

  1. Front Matter

    Pages I-XIV
    Download chapter PDF

  2. Historical perspective: from early steps on calcium research to the identification of calcium antagonist prototypes and of the signaling functions of Ca2+

    • Théophile Godfraind
    Pages 1-9

  3. Calcium channel blockers and calcium channels

    • Eric Ertel, Théophile Godfraind
    Pages 11-80

  4. The action of calcium antagonists on Ca2+ movements in isolated vessels

    • Théophile Godfraind
    Pages 81-112

  5. The tissue selectivity of calcium antagonists

    • Théophile Godfraind
    Pages 113-129

  6. Acute haemodynamic effects of calcium channel blockers

    • Théophile Godfraind
    Pages 131-149

  7. Calcium channels and regulation of vascular tone in hypertension

    • Théophile Godfraind
    Pages 151-159

  8. Long-term effects of calcium antagonists

    • Théophile Godfraind
    Pages 161-179

  9. Blood pressure-independent effects of calcium antagonists

    • Théophile Godfraind
    Pages 181-197

  10. From early clinical studies to randomized controlled clinical trials

    • Théophile Godfraind
    Pages 199-236

  11. Beyond the cardiovascular system

    • Théophile Godfraind
    Pages 237-254

  12. Back Matter

    Pages 255-262
    Download chapter PDF
Back to top

Keywords

About this book

The drugs named calcium channel blockers (CCBs) were initially termed cal­ cium antagonists (see Chapter 1). They are also designated as calcium entry blockers (CEBs), calcium blockers, calcium channel antagonists, calcium channel inhibitors (and in French anticalciques). As this is reported in several chapters of this book, their main effect is a blockade of calcium entry into cells through voltage operated calcium channels (VOCCs). Chemically related drugs, such as Bay K 8644, exert the opposite effect by increasing the proba­ bility of calcium channel opening. One of the subcommittees of the Nomenclature Committee (NC-IUPAR) of the International Union of Pharmacology has been devoted to the classification of calcium channels and the site of action of drugs modifying channel function. The members of this Committee are noted for their significant contribution to the field (Tab. 1). A report has been published in 1992 in Pharmacological Reviews [3]. A list of criteria was approved for the identification of distinct drug binding 2 sites on Ca + channels. It included: (a) the demonstration of a stereoselective binding site supported by drug interaction studies (competition with other drugs, non-competitive interactions with other sites, reversal of inhibitory effects by channel activators); (b) demonstration of the electrophysiologieal effects of the drug and selectivity of action compared to other sites; (c) deter­ mination of the affinity for the type and subtype of ion channel. These criteria have identified different classes of Ca antagonists (see Chapter 2).

Authors and Affiliations

  • Université Catholique de Louvain, Bruxelles, Belgium

    Théophile Godfraind

Bibliographic Information

  • Book Title: Calcium Channel Blockers

  • Authors: Théophile Godfraind

  • Series Title: Milestones in Drug Therapy

  • DOI: https://doi.org/10.1007/978-3-0348-7859-3

  • Publisher: Birkhäuser Basel

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Basel AG 2004

  • Hardcover ISBN: 978-3-7643-6435-9Published: 26 March 2004

  • Softcover ISBN: 978-3-0348-9599-6Published: 05 November 2012

  • eBook ISBN: 978-3-0348-7859-3Published: 06 December 2012

  • Series ISSN: 2296-6056

  • Series E-ISSN: 2296-6064

  • Edition Number: 1

  • Number of Pages: XIV, 262

  • Topics: Pharmacology/Toxicology, Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation